Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)
| 45.15 Delayed Data As of Oct 15 |  -0.52 / -1.14%Today’s Change | 24.87 Today|||52-Week Range 129.71 | +4.08% Year-to-Date |
Latest ARCT News | Press Releases
| 3 Beaten-Down Stocks Cathie Wood Is Buying That Wall Street Thinks Will Skyrocket Oct 19 / MotleyFool.com - Paid Partner Content | Cathie Wood Just Bought Shares of This Vaccine Underdog. Should You? Oct 15 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 45.69 |
| Today’s open | 45.89 |
| Day’s range | 44.40 - 47.18 |
| Volume | 349,843 |
| Average volume (3 months) | 761,000 |
| Market cap | $1.2B |
Data as of 3:59pm ET, 10/15/2021
Growth & Valuation
| Earnings growth (last year) | -65.00% |
| Earnings growth (this year) | -92.60% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -54.12% |
| P/E ratio | NM |
| Price/Sales | 92.34 |
| Price/Book | 3.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MGNXMacroGenics Inc | -0.14 | -0.71% |
| KURAKura Oncology Inc | +0.23 | +1.31% |
| YMABY-mAbs Therapeutics ... | -0.07 | -0.26% |
| INVAInnoviva Inc | +0.18 | +1.11% |
Data as of 3:59pm ET, 10/15/2021
Financials
| Next reporting date | November 11, 2021 |
| EPS forecast (this quarter) | -$1.50 |
| Annual revenue (last year) | $9.5M |
| Annual profit (last year) | -$72.1M |
| Net profit margin | -756.35% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
